Brexpiprazole in patients with schizophrenia: overview of short- and long-term phase 3 controlled studies.

Author: HakalaMika Juhani, HobartMary, JosiassenMette Krog, MarderStephen R, OuyangJohn, WeillerEmmanuelle, WeissCatherine, ZhangPeter

Paper Details 
Original Abstract of the Article :
OBJECTIVE: Review efficacy, safety, and tolerability of brexpiprazole in patients with schizophrenia in short- and long-term phase 3 studies. METHODS: Patients experiencing a current exacerbation of schizophrenia received brexpiprazole in two fixed-dose (2 and 4 mg), 6-week, placebo-controlled stud...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1017/neu.2016.57

データ提供:米国国立医学図書館(NLM)

Brexpiprazole: A New Oasis in the Desert of Schizophrenia Treatment

The field of schizophrenia treatment is a vast and often challenging desert, with researchers constantly seeking to develop new therapies to improve patient outcomes. This study explores the efficacy and safety of brexpiprazole, a novel antipsychotic drug, in patients with schizophrenia. The authors meticulously examine the results of several short- and long-term phase 3 studies, highlighting brexpiprazole's potential as a safe and effective treatment option for schizophrenia. They emphasize brexpiprazole's ability to reduce psychotic symptoms, improve social functioning, and maintain treatment benefits over time.

Brexpiprazole: A Potential Oasis in the Desert of Schizophrenia Treatment

The results of this study suggest that brexpiprazole could be a valuable tool for managing schizophrenia. Its efficacy in reducing psychotic symptoms, improving social functioning, and maintaining treatment benefits over time offers hope for those struggling with this debilitating condition. These findings, like a refreshing oasis in the desert, provide a new avenue for treating schizophrenia and improving the lives of those affected.

Navigating the Desert of Schizophrenia: New Treatments for a Challenging Journey

This research is a reminder that even in the challenging landscape of schizophrenia, there is room for hope and progress. The development of new treatments like brexpiprazole offers a glimmer of hope for patients and their families. By continuing to explore and develop new treatment options, we can create a more navigable path through the desert of schizophrenia, leading to better outcomes for those affected by this condition. Remember, the journey through the desert can be long and arduous, but with perseverance and the right tools, we can find our way to a more comfortable and fulfilling destination.

Dr.Camel's Conclusion

This study highlights the importance of perseverance in the quest for effective schizophrenia treatments. Brexpiprazole, like a newly discovered oasis in the desert, offers a glimmer of hope, providing a safe and effective treatment option for those struggling with this challenging condition. It's a reminder that even in the most difficult deserts, we can find our way to a better future.

Date :
  1. Date Completed 2018-05-22
  2. Date Revised 2018-05-22
Further Info :

Pubmed ID

27846922

DOI: Digital Object Identifier

10.1017/neu.2016.57

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.